Columbia Laboratories (CBRX) is the Chart of the Day. The women's healthcare pharmaceutical company has recently taken off with 17 new highs and up 52.05% in the last month.
Article:
The Chart of the Day is Columbia Laboratories (CBRX). I found the stock by sorting the New High List for frequency. The stock languished until an analysts predicted the earning would be up 75.00% this year, then the price started to move and begin trading over 100K shares a day.
It is in the business of developing, manufacturing and selling pharmaceutical products that utilize their proprietary bioadhesive drug delivery technologies to treat various medical conditions. Their focus is developing drugs that improve treatment options for women's health, an area where they have a rich heritage and proven capabilities. Their strategy is to fund development through proof-of-concept, then partner for later-stage clinical trials and commercialization.
Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the Barchart.com web site when you read this report.
Barchart technical indicators:
- 96% Barchart technical buy signals
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 17 new highs and up 52.05% in the last month
- Relative Strength Index 78.22%
- Barchart computes a technical support level at 7.81
- Recently traded at 8.15 with a 50 day moving average of 6.26
Fundamental factors:
- Market Cap $89.32 million
- P/E 14.30
- Revenue predicted to grow by 2.90% this year and another 10.00% next year
- Earnings estimated to increase 75.00% this year and another 42.90% next year
- A Wall Street analysts recommends a buy
- Financial Strength is a C++
This stock has a small cap and a large volume. Do not buy and put it on a shelf but watch the 50 day moving average and Relative Strength Index closely.
No comments:
Post a Comment